Search research articles
Contact Us
Filters
Showing results (151-160 of 167) with videos related to
Page
of 17
Sort By:
Plos One
|
August 4, 2017
A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa
Yasmeen Hanifa, Katherine L Fielding, Violet N Chihota, et al.
PLOS Digital Health
|
June 12, 2023
Improving outcomes for children with malaria, diarrhoea and pneumonia in Mozambique: A cluster randomised controlled trial of the inSCALE technology innovation
Seyi Soremekun, Karin Källander, Raghu Lingam, et al.
Plos Medicine
|
November 17, 2011
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis
Anna Vassall, Sanne van Kampen, Hojoon Sohn, et al.
Gates Open Research
|
February 12, 2021
What next after GDP-based cost-effectiveness thresholds?
Y-Ling Chi, Mark Blecher, Kalipso Chalkidou, et al.
The Lancet. Global Health
|
July 19, 2015
Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF
Gavin J Churchyard, Wendy S Stevens, Lerole D Mametja, et al.
Plos Medicine
|
July 18, 2024
Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study
Gabrielle Bonnet, John Bimba, Chancy Chavula, et al.
The Lancet. Global Health
|
October 14, 2017
Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study
Stéphane Verguet, Carlos Riumallo-Herl, Gabriela B Gomez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 21, 2018
Cost and Cost-Effectiveness of a Demand Creation Intervention to Increase Uptake of Voluntary Medical Male Circumcision in Tanzania: Spending More to Spend Less
Sergio Torres-Rueda, Mwita Wambura, Helen A Weiss, et al.
BMJ Global Health
|
December 3, 2021
Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries
Sergio Torres-Rueda, Sedona Sweeney, Fiammetta Bozzani, et al.
African Journal of AIDS Research : AJAR
|
November 30, 2019
Meta-analysis of average costs of HIV testing and counselling and voluntary medical male circumcision across thirteen countries
Carlos Pineda-Antunez, Gisela Martinez-Silva, Diego Cerecero-Garcia, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 167) with videos related to
Sort By:
Page
of 17
Plos One
|
August 4, 2017
A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa
Yasmeen Hanifa, Katherine L Fielding, Violet N Chihota, et al.
PLOS Digital Health
|
June 12, 2023
Improving outcomes for children with malaria, diarrhoea and pneumonia in Mozambique: A cluster randomised controlled trial of the inSCALE technology innovation
Seyi Soremekun, Karin Källander, Raghu Lingam, et al.
Plos Medicine
|
November 17, 2011
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis
Anna Vassall, Sanne van Kampen, Hojoon Sohn, et al.
Gates Open Research
|
February 12, 2021
What next after GDP-based cost-effectiveness thresholds?
Y-Ling Chi, Mark Blecher, Kalipso Chalkidou, et al.
The Lancet. Global Health
|
July 19, 2015
Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF
Gavin J Churchyard, Wendy S Stevens, Lerole D Mametja, et al.
Plos Medicine
|
July 18, 2024
Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study
Gabrielle Bonnet, John Bimba, Chancy Chavula, et al.
The Lancet. Global Health
|
October 14, 2017
Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study
Stéphane Verguet, Carlos Riumallo-Herl, Gabriela B Gomez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 21, 2018
Cost and Cost-Effectiveness of a Demand Creation Intervention to Increase Uptake of Voluntary Medical Male Circumcision in Tanzania: Spending More to Spend Less
Sergio Torres-Rueda, Mwita Wambura, Helen A Weiss, et al.
BMJ Global Health
|
December 3, 2021
Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries
Sergio Torres-Rueda, Sedona Sweeney, Fiammetta Bozzani, et al.
African Journal of AIDS Research : AJAR
|
November 30, 2019
Meta-analysis of average costs of HIV testing and counselling and voluntary medical male circumcision across thirteen countries
Carlos Pineda-Antunez, Gisela Martinez-Silva, Diego Cerecero-Garcia, et al.
Page
of 17